Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the stock […]
Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price target raised by Bank of America from $52.00 to $56.00 in a research report sent to investors on Tuesday, Benzinga reports. Bank of America currently has a buy rating on the biopharmaceutical company’s stock. Several other research firms have also recently weighed in on XENE. StockNews.com […]
Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $52.40 Average PT from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the stock, MarketBeat Ratings reports. Ten research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price […]